Funded under the National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3, Theme 10.
Identification of nutrient and non-nutrient food components (and their metabolic products) potentially involved in the promotion of consumer health, and evaluation of their bio accessibility, bioavailability, and effect on the gut microbiota, using in silico, in vitro, ex vivo and in vivo approaches on humans/animals to confirm the actual absorption and bioactivity of non-nutrient components also considering specific dietary patterns and target groups.
Evaluation of the bioavailability and bioactivity of at least two components of foods proven to directly impact human health (M36)
Identification of novel food-derived compounds (and their metabolic products) in human body fluids/tissues that are associated with a putative bioactivity and/or a possible health effect (M30)
In plant-based foods, cell wall is crucial for nutrient bioaccessibility because of it is composed by cellulose microfibrils integrated within a gel-type matrix typically comprising pectin, hemicellulose, and small amounts of glycoproteins, phenolic acids, minerals and lignin. The rupture of the cell wall is an important requisite for digestion. Moreover, the cell wall matrix and individual cell wall polysaccharides in plants behave in a similar way during digestion. The cell walls characterized by a high permeability or more prone to physical disruption release nutrients easily, rendering them more bioaccessible. Thus, the nutrient accessibility to digestion within the human gastro-intestinal tract varies in relation to the plant species and the plant organ used as food. Animal-based nutrients have a higher bioavailability than plant-based foods, and they are less likely to cause problems with antinutrients.
The experimental plan will be structured with the following objectives: